227 related articles for article (PubMed ID: 22465143)
1. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.
Goldenstein H; Levy NS; Levy AP
Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Asleh R; Levy AP
Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
[TBL] [Abstract][Full Text] [Related]
3. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
4. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
Asleh R; Marsh S; Shilkrut M; Binah O; Guetta J; Lejbkowicz F; Enav B; Shehadeh N; Kanter Y; Lache O; Cohen O; Levy NS; Levy AP
Circ Res; 2003 Jun; 92(11):1193-200. PubMed ID: 12750308
[TBL] [Abstract][Full Text] [Related]
5. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.
Purushothaman M; Krishnan P; Purushothaman KR; Baber U; Tarricone A; Perez JS; Wiley J; Kini A; Sharma SK; Fuster V; Moreno PR
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2769-75. PubMed ID: 22982461
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.
Asleh R; Guetta J; Kalet-Litman S; Miller-Lotan R; Levy AP
Circ Res; 2005 Mar; 96(4):435-41. PubMed ID: 15662028
[TBL] [Abstract][Full Text] [Related]
7. Patient selection and vitamin E treatment in diabetes mellitus.
Goldenstein H; Levy NS; Lipener YT; Levy AP
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):319-26. PubMed ID: 23469912
[TBL] [Abstract][Full Text] [Related]
8. Hypothesis--haptoglobin genotype and diabetic nephropathy.
Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
[TBL] [Abstract][Full Text] [Related]
9. Haptoglobin: From hemoglobin scavenging to human health.
di Masi A; De Simone G; Ciaccio C; D'Orso S; Coletta M; Ascenzi P
Mol Aspects Med; 2020 Jun; 73():100851. PubMed ID: 32660714
[TBL] [Abstract][Full Text] [Related]
10. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
Vardi M; Levy AP
Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
[TBL] [Abstract][Full Text] [Related]
12. Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.
Mollan TL; Jia Y; Banerjee S; Wu G; Kreulen RT; Tsai AL; Olson JS; Crumbliss AL; Alayash AI
Free Radic Biol Med; 2014 Apr; 69():265-77. PubMed ID: 24486321
[TBL] [Abstract][Full Text] [Related]
13. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
[TBL] [Abstract][Full Text] [Related]
14. Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.
Armaly Z; Abd El Qader A; Jabbour A; Hassan K; Ramadan R; Bowirrat A; Bisharat B
BMC Nephrol; 2015 Aug; 16():135. PubMed ID: 26268514
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin binding stabilizes hemoglobin ferryl iron and the globin radical on tyrosine β145.
Cooper CE; Schaer DJ; Buehler PW; Wilson MT; Reeder BJ; Silkstone G; Svistunenko DA; Bulow L; Alayash AI
Antioxid Redox Signal; 2013 Jun; 18(17):2264-73. PubMed ID: 22702311
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.
Bamm VV; Tsemakhovich VA; Shaklai M; Shaklai N
Biochemistry; 2004 Apr; 43(13):3899-906. PubMed ID: 15049697
[TBL] [Abstract][Full Text] [Related]
17. The Staphylococcus aureus Protein IsdH Inhibits Host Hemoglobin Scavenging to Promote Heme Acquisition by the Pathogen.
Sæderup KL; Stødkilde K; Graversen JH; Dickson CF; Etzerodt A; Hansen SW; Fago A; Gell D; Andersen CB; Moestrup SK
J Biol Chem; 2016 Nov; 291(46):23989-23998. PubMed ID: 27681593
[TBL] [Abstract][Full Text] [Related]
18. Can gas replace protein function? CO abrogates the oxidative toxicity of myoglobin.
Sher EA; Sholto AY; Shaklai M; Shaklai N
PLoS One; 2014; 9(8):e104075. PubMed ID: 25111140
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin polymorphism and body iron stores.
Delanghe JR; Langlois MR
Clin Chem Lab Med; 2002 Mar; 40(3):212-6. PubMed ID: 12005209
[TBL] [Abstract][Full Text] [Related]
20. Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin.
Pimenova T; Pereira CP; Gehrig P; Buehler PW; Schaer DJ; Zenobi R
J Proteome Res; 2010 Aug; 9(8):4061-70. PubMed ID: 20568812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
